Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)

Clinical trial NCT05632445 · COMPLETED

Trial details

NCT number: NCT05632445
Sponsor: DR. XAVIER FREIXA
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Left Atrial Appendage Occlusion

Start date: 2019-05-01
Primary completion: 2019-06-12
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.